Allworth Financial’s VolitionRx Ltd VNRX Stock Holding History

Allworth Financial’s Portfolio VNRX Stock Details VNRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-10	Closed	-$136	–	5297
2025 Q3	$136	Hold	10	–	–	﹤0.01%	4646
2025 Q2	$152	Hold	10	–	–	﹤0.01%	4353
2025 Q1	$98	Hold	10	–	–	﹤0.01%	3953
2024 Q4	$123	Hold	10	–	–	﹤0.01%	3829
2024 Q3	$121	Hold	10	–	–	﹤0.01%	3648
2024 Q2	$142	Hold	10	–	–	﹤0.01%	3586
2024 Q1	$152	Hold	10	–	–	﹤0.01%	3475
2023 Q4	$144	Hold	10	–	–	﹤0.01%	3321
2023 Q3	$138	Hold	10	–	–	﹤0.01%	3281
2023 Q2	$278	Hold	10	–	–	﹤0.01%	3034
2023 Q1	$382	Buy	+10	New	+$418	﹤0.01%	2894

Other funds holding VNRX

LIM

Lagoda Investment Management New York $162M AUM 49.7% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

SBCM

Silverberg Bernstein Capital Management Armonk, New York $261M AUM 89.93% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Squarepoint New York $85.1B AUM 20.93% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Allworth Financial's VNRX Position: Q4 2025 in Review

Allworth Financial sold out of VolitionRx Ltd (VNRX) in Q4 2025, closing a stake of 10 shares — an estimated $136 sold.

Allworth Financial first reported a position in VNRX in Q1 2023 and held it in 11 quarters. The position peaked at $382 in Q1 2023. 28 funds tracked by Wall St. Rank hold VNRX as of Q4 2025.

Allworth Financial reported no remaining VolitionRx Ltd position as of Q4 2025 after selling out during the quarter.
Allworth Financial sold 10 VolitionRx Ltd shares in Q4 2025, an estimated $136.
Allworth Financial first reported a position in VolitionRx Ltd in Q1 2023 and held it in 11 quarters.
Allworth Financial's VolitionRx Ltd position peaked at $382 in Q1 2023.
28 funds tracked by Wall St. Rank held VolitionRx Ltd as of Q4 2025.

Based on Allworth Financial's 13F filing for Q4 2025, filed 5 Feb 2026.